WuXi NextCODE Genomics:製薬・医療:M&Aディール及び事業提携情報

【英語タイトル】WuXi NextCODE Genomics - Pharmaceuticals & Healthcare - Deals and Alliances Profile

GlobalDataが出版した調査資料(DATA904C10609)・商品コード:DATA904C10609
・発行会社(調査会社):GlobalData
・発行日:2018年11月
・ページ数:29
・レポート言語:英語
・レポート形式:PDF
・納品方法:Eメール
・産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※納期:即日〜2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・郵送(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
【レポートの概要】

Summary
WuXi NextCODE Genomics USA Inc (WuXi NextCODE), a subsidiary of Wuxi Pharmatech (Cayman) Inc, is a genomic information company that offers competencies in generating, organizing, mining, sharing and applying genomic data. The company develops gene sequence analysis platform and database architecture, which enables clinicians and researchers across the globe to use the power of next-generation sequencing data to better diagnose and treat diseases. WuXi NextCODE’s services comprise genome analysis and interpretation, big data management and storage, custom integration and next generation sequencing. It has operations in Shanghai, Cambridge and Reykjavik. WuXi NextCODE is headquartered in Cambridge, Massachusetts, the US.

WuXi NextCODE Genomics – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
WuXi NextCODE Genomics, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
WuXi NextCODE Genomics, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
WuXi NextCODE Genomics, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
WuXi NextCODE Genomics, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
WuXi NextCODE Genomics, Medical Devices Deals, 2012 to YTD 2018 9
WuXi NextCODE Genomics, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
WuXi NextCODE Genomics, Pharmaceuticals & Healthcare, Deal Details 11
Venture Financing 11
DNAnexus Raises USD58 Million in Equity Financing 11
WuXi NextCODE Raises Additional USD165 Million in Series B Financing 13
NextCode Health Raises USD15 Million in Series A Financing 14
Partnerships 15
WuXi NextCode Enters into Partnership with Rhythm Pharma 15
AbbVie Enters into Agreement with Genomics Medicine Ireland and WuXi NextCODE Genomics 16
Genomics England Enters into Contract Agreement with WuXi NextCODE 17
SA1KCGP, WuXi NextCODE and START Enter into Partnership 18
WuXi NextCODE Genomics Enters into Agreement with Sidra Medical and Research Center 19
NextCode Health Enters into Licensing Agreement with deCode Genetics for Clinical Diagnostics 20
Acquisition 21
WuXi PharmaTech Acquires NextCODE Health for USD65 Million 21
WuXi NextCODE Genomics – Key Competitors 22
WuXi NextCODE Genomics – Key Employees 23
WuXi NextCODE Genomics – Locations And Subsidiaries 24
Head Office 24
Other Locations & Subsidiaries 24
Recent Developments 25
Corporate Communications 25
Apr 15, 2018: WuXi NextCODE Appoints Richard Williams As Managing Director And Head Of Oncology Programs 25
Mar 12, 2018: WuXi NextCODE Appoints Rob Brainin As Chief Executive Officer 26
Feb 28, 2017: WuXi NextCODE Appoints Hannes Smarason as CEO, John Long as CFO, and Alex Fowkes as COO 27
Government and Public Interest 28
Feb 28, 2017: China plans leading role in ‘precision medicine’ field 28
Appendix 29
Methodology 29
About GlobalData 29
Contact Us 29
Disclaimer 29

List of Tables
WuXi NextCODE Genomics, Pharmaceuticals & Healthcare, Key Facts 2
WuXi NextCODE Genomics, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
WuXi NextCODE Genomics, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
WuXi NextCODE Genomics, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
WuXi NextCODE Genomics, Deals By Therapy Area, 2012 to YTD 2018 8
WuXi NextCODE Genomics, Medical Devices Deals, 2012 to YTD 2018 9
WuXi NextCODE Genomics, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
DNAnexus Raises USD58 Million in Equity Financing 11
WuXi NextCODE Raises Additional USD165 Million in Series B Financing 13
NextCode Health Raises USD15 Million in Series A Financing 14
WuXi NextCode Enters into Partnership with Rhythm Pharma 15
AbbVie Enters into Agreement with Genomics Medicine Ireland and WuXi NextCODE Genomics 16
Genomics England Enters into Contract Agreement with WuXi NextCODE 17
SA1KCGP, WuXi NextCODE and START Enter into Partnership 18
WuXi NextCODE Genomics Enters into Agreement with Sidra Medical and Research Center 19
NextCode Health Enters into Licensing Agreement with deCode Genetics for Clinical Diagnostics 20
WuXi PharmaTech Acquires NextCODE Health for USD65 Million 21
WuXi NextCODE Genomics, Key Competitors 22
WuXi NextCODE Genomics, Key Employees 23
WuXi NextCODE Genomics, Other Locations 24

List of Figures
WuXi NextCODE Genomics, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
WuXi NextCODE Genomics, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
WuXi NextCODE Genomics, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
WuXi NextCODE Genomics, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
WuXi NextCODE Genomics, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
WuXi NextCODE Genomics, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
WuXi NextCODE Genomics, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
WuXi NextCODE Genomics, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
WuXi NextCODE Genomics, Medical Devices Deals, 2012 to YTD 2018 9

★調査レポート[WuXi NextCODE Genomics:製薬・医療:M&Aディール及び事業提携情報] (コード:DATA904C10609)販売に関する免責事項を必ずご確認ください。
★調査レポート[WuXi NextCODE Genomics:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆